Ventilatory support and corticosteroid therapy in SARS-CoV-2.

Area of Science:

• Infectious Diseases
• Pulmonology
• Critical Care Medicine

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, has presented significant challenges to the medical community.
• Effective therapeutic strategies are crucial for managing patients with severe respiratory failure.
• While antivirals show mixed results, supportive care is vital.

Purpose of the Study:

• To review the established role of corticosteroids in managing COVID-19.
• To discuss the principles of ventilatory support for SARS-CoV-2 patients.
• To highlight these as essential therapeutic pillars.

Main Methods:

• Literature review focusing on corticosteroid therapy in COVID-19.
• Analysis of established guidelines and evidence for ventilatory support.
• Synthesis of information on managing respiratory failure in SARS-CoV-2.

Main Results:

• Corticosteroids have demonstrated efficacy in reducing inflammation and improving outcomes in certain COVID-19 patients.
• Mechanical ventilation and lung-protective strategies are critical for patients with acute respiratory distress syndrome (ARDS) due to SARS-CoV-2.
• These interventions have become cornerstones of intensive care for severe COVID-19.

Conclusions:

• Corticosteroids and ventilatory support are indispensable components of COVID-19 critical care.
• Optimizing these therapies is essential for improving survival rates in hospitalized patients with respiratory failure.
• Further research may refine their application, but their current importance is undeniable.